Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. kreativ health inc
WARNING LETTER
•kreativ health inc •July 31, 2012

kreativ health inc – FDA Warning Letter, Jul 31, 2012

Record Details

The FDA conducted an inspection of Kreativ Health, Inc. dba Natural Food Supplements from July 26-31, 2012, revealing significant Current Good Manufacturing Practice (CGMP) violations under 21 CFR Part 111, rendering their dietary supplements adulterated. Key CGMP deficiencies included failure to conduct identity testing for dietary ingredients, establish component and product specifications, qualify suppliers, implement laboratory control processes for sampling, approve and release components/packaging/labels from quarantine, document quality control approval in batch records, maintain written equipment procedures, ensure proper packaging/labeling via master manufacturing records, establish complete batch production records, keep training documentation, and establish written procedures for product complaints and returned dietary supplements. Beyond CGMP, several products were found to be misbranded under sections 403(q)(5)(F), 403(i)(1), 403(s)(2)(B), and 403(y) of the Act and 21 CFR Part 101. Misbranding issues included lacking "Supplement Facts" panels, failing to identify products as "dietary supplements," and omitting domestic adverse event reporting contact information. Furthermore, the "Super MSM" product was deemed an unapproved new drug under sections 201(g)(1)(B) and 201(p) of the Act due to disease treatment claims ("relieves joint pain") without FDA approval. The firm's responses to the FDA-483 were largely inadequate. FDA requires prompt corrective actions, a written response within 15 working days detailing steps taken, and a timetable for remaining corrections, warning of potential regulatory actions like product seizure or injunctions, and reinspection fees.

Company
kreativ health inc
Inspection date
July 31, 2012
Product type
Food
Office
Los Angeles District Office
Person
  • Alonza E. Cruse (Director)
View Company Profile

ID · 0de74b92-f729-47ac-85f6-c43a960e2d84

Violation Codes10
21 CFR 11121 U.S.C. 342(g)(1)21.U.S.C. 355(a)21 CFR 10121 CFR 111.75(a)(1)(i)21 CFR 111.75(a)(1)(ii)21 CFR 111.70(b)(2)21 CFR 111.70(f)21 CFR 111.75(a)(2)(ii)(A)21 CFR 111.75(a)(2)(ii)(C)

Full citation text and observation details available on the Dashboard.

Other documents for kreativ health inc
  • WARNING_LETTER - 2015-08-31August 31, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore kreativ health inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.